| E-mail： chenjincao@hotmail.com |
Biography
Personal Profile
Dean of the Brain Hospital and Director of the Department of Neurosurgery, Zhongnan Hospital of Wuhan University; Chief Physician, Professor, and Doctoral Supervisor.
With over 30 years of clinical experience in neurosurgery, he is particularly proficient in the microsurgical treatment of cerebrovascular diseases (such as aneurysms, arteriovenous malformations, and moyamoya disease) and the comprehensive treatment of skull base tumors including acoustic neuromas and pineal region tumors. He ranked among the top 10 in cerebrovascular surgery in the National Top 100 Famous Doctors List.
Leading his team, he has achieved outstanding results in the clinical practice and scientific research of moyamoya disease. He innovated the "Dujiangyan-style" bypass surgery, which has gained international recognition and been published in top international professional journals.
Educational Background
September 1981 - July 1986: Bachelor's Degree in Clinical Medicine, Department of Clinical Medicine, Tongji Medical College, Huazhong University of Science and Technology
September 1987 - July 1990: Master's Degree in Surgery (Neurosurgery), Tongji Medical College, Huazhong University of Science and Technology
September 1990 - July 1993: Doctoral Degree in Surgery (Neurosurgery), Tongji Medical College, Huazhong University of Science and Technology
October 1999 - November 2000: Postdoctoral Fellow at the Cerebrovascular Disease Research Center, University Hospital of Basel, Switzerland
Work Experience
July 1993 - October 2015: Department of Neurosurgery, Tongji Hospital Affiliated to Huazhong University of Science and Technology
October 2015 - Present: Director of the Department of Neurosurgery, Zhongnan Hospital of Wuhan University
Honors and Awards
2016: Selected as one of the "My Ideal Doctors" in the 4th Session hosted by Wuhan Evening News
2017: Named "Advanced Worker in the National Health and Family Planning System"
2018: Honored as "Jingchu Model - Most Beautiful Health and Family Planning Worker"
2019: Selected as the "Chinese Good Doctor and Good Nurse" Monthly Figure through online recommendation and evaluation jointly initiated by the Central Civilization Office and the National Health Commission
2022: Named "Hubei Provincial Advanced Worker"
2023: Re-elected as "Hubei Provincial Advanced Worker"; Won the "National Famous Doctor - Outstanding Achievement" Award by People's Daily Online
Social Services
2019 - Present: Chairman of the Neurosurgery Branch of Hubei Medical Association
2018 - Present: Review Expert (Second Round) of the National Natural Science Foundation of China
2018 - Present: Vice Chairman of the Cerebrovascular Disease Committee of the Neurosurgery Branch of the Chinese Medical Doctor Association
2019 - Present: Vice Chairman of the Neural Minimally Invasive Treatment Professional Committee of the Chinese Research Hospital Association
2020 - Present: Chairman of the Cerebrovascular Disease Branch of the Medical Doctors Association of the Western Returned Scholars Association
Teaching Courses
Advances in Neurosurgery (for postgraduates)
Advances in Combined Cerebrovascular Surgery Treatment (for postgraduates)
Research
His research focuses on cerebrovascular diseases and Alzheimer's disease. In the past 5 years, he innovated the "Dujiangyan-style" bypass surgery for moyamoya disease, reducing the postoperative symptomatic hyperperfusion rate to below 5% and benefiting over 700 patients. The relevant technology has won 2 Second Prizes of the Hubei Provincial Science and Technology Progress Award. In the future, he plans to develop cerebrospinal fluid replacement equipment to advance the treatment of Alzheimer's disease and explore the inflammatory mechanism of moyamoya disease using single-cell sequencing.
In terms of academic papers, he has published research results in top-tier journals such as Journal of Neurosurgery and Chest. In the past 5 years, his core papers have focused on directions including blood flow regulation in moyamoya disease. The department he leads has published more than 200 academic papers in the past 3 years.
Regarding research projects, he has presided over 3 National Natural Science Foundation of China (NSFC) projects (e.g., "TUG1-Mediated Vascular Inflammation and the Mechanism of Moyamoya Disease") and 1 Major Technological Innovation Project of Hubei Province, with a total funding of over 3.8 million yuan.
In addition, he led the compilation of Expert Consensus on Surgical Treatment of Moyamoya Disease in China (2024 Edition) and served as the chief translator of Surgical Techniques for Moyamoya Angiopathy. He has obtained 3 Chinese invention patents, including one for the "Novel Adjustable Pressure Suction Tip". The department he leads has received 81 authorized patents and undertaken 40 research projects at all levels in the past 3 years.
Representative Publications
Ma Xiaoqi#, Liu Wen#, Li Zhipeng, Zhan Jiale, Wang Aijun, Yuan Peixin, Chen Jincao*, Feng Jiuju*；The high-efficiency PEC material prepared by porphyrin grafted with Au nanoparticles embedded in porous carbon for PTK-7 detection, Sensors and Actuators B-Chemical, 2024, 403
Jianjian Zhang#, Sirui Li, Miki Fujimura, Tsz Yeung Lau, Xiaolin Wu, Miao Hu, Hanpei Zheng, Haibo Xu, Wenyuan Zhao, Xiang Li, Jincao Chen*；Hemodynamic analysis of the recipient parasylvian cortical arteries for predicting postoperative hyperperfusion during STA-MCA bypass in adult patients with moyamoya disease, Journal of Neurosurgery, 2019, 134, 17-24
Wei Wang#, Can Xin#, Zhongwei Xiong#, Xixi Yan, Yuankun Cai, Keyao Zhou, Chuanshun Xie, Tingbao Zhang, Xiaohui Wu, Kui Liu, Zhiqiang Li, Jincao Chen*；Clinical Characteristics and Outcomes of 421 Patients With Coronavirus Disease 2019 Treated in a Mobile Cabin Hospital, Chest, 2020, 158, 939-946
Sen Ren#, Du Wu, Xiaoyong Shen, Qian Wu, Chengcheng Li, Hewei Xiong, Zhongwei Xiong, Rui Gong, Zheng Liu* , Wei Wang*, Jincao Chen*；Deciphering the role of extrachromosomal circular DNA in adipose stem cells from old and young donors, Stem Cell Research & Therapy, 2023, 14, 341
Wang Meiyao#, Xu Huazhen, Li Tongfei, Li Ke, Zhang Quan, Chen Siyi, Zhao Li, Chen Jincao*, Chen Xiao*；Sonodynamic therapy of glioblastoma mediated by platelets with ultrasound-triggered drug release, Drug Delivery, 2023, 30
